Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world Impact of Fremanezumab on Migraine-Related Health Care Resource Utilization in Patients with Comorbidities, Acute Medication Overuse, and/or Unsatisfactory Prior Migraine Preventive Response.
Buse DC, Krasenbaum LJ, Seminerio MJ, Packnett ER, Carr K, Ortega M, Driessen MT. Buse DC, et al. Among authors: krasenbaum lj. Pain Ther. 2024 Jun;13(3):511-532. doi: 10.1007/s40122-024-00583-9. Epub 2024 Mar 12. Pain Ther. 2024. PMID: 38472655 Free PMC article.
Clinical characteristics and patient-reported outcomes of chronic and episodic migraine patients at a US tertiary headache center: A retrospective observational study.
Ahmed Z, Honomichl R, Thompson SF, Cohen JM, Schuster A, Thompson NR, Lapin B, Udeh BL, Ramirez Campos V, Krasenbaum LJ, Katzan IL. Ahmed Z, et al. Among authors: krasenbaum lj. Headache. 2023 Jul-Aug;63(7):908-916. doi: 10.1111/head.14527. Epub 2023 Jun 14. Headache. 2023. PMID: 37314065
Commentary: Constipation caused by anti-calcitonin gene-related peptide migraine therapeutics explained by antagonism of calcitonin gene-related peptide's motor-stimulating and prosecretory function in the intestine.
Mackenzie KD, Ortega M, Kessler Y, Campos VR, Krasenbaum LJ, Carr K, Ning X, Stratton J. Mackenzie KD, et al. Among authors: krasenbaum lj. Front Physiol. 2022 Nov 29;13:1067274. doi: 10.3389/fphys.2022.1067274. eCollection 2022. Front Physiol. 2022. PMID: 36523559 Free PMC article.
Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies.
Nahas SJ, Naegel S, Cohen JM, Ning X, Janka L, Campos VR, Krasenbaum LJ, Holle-Lee D, Kudrow D, Lampl C. Nahas SJ, et al. Among authors: krasenbaum lj. J Headache Pain. 2022 May 17;23(1):57. doi: 10.1186/s10194-022-01423-x. J Headache Pain. 2022. PMID: 35581545 Free PMC article. No abstract available.
Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies.
Nahas SJ, Naegel S, Cohen JM, Ning X, Janka L, Campos VR, Krasenbaum LJ, Holle-Lee D, Kudrow D, Lampl C. Nahas SJ, et al. Among authors: krasenbaum lj. J Headache Pain. 2021 Nov 24;22(1):141. doi: 10.1186/s10194-021-01351-2. J Headache Pain. 2021. PMID: 34819017 Free PMC article. Clinical Trial.
Comment on: Gao B, Lu Q, Wan R, Wang Z, Yang Y, Chen Z, Wang Z. "Monthly versus quarterly fremanezumab for the prevention of migraine: a systemic review and meta-analysis from randomized controlled trials". Naunyn Schmiedebergs Arch Pharmacol. 2021 Apr;394(4):819-828. Epublished November 2020.
Barash S, Ramirez Campos V, Ning X, Driessen MT, Krasenbaum LJ, Carr K, Cohen JM. Barash S, et al. Among authors: krasenbaum lj. Naunyn Schmiedebergs Arch Pharmacol. 2021 Nov;394(11):2343-2346. doi: 10.1007/s00210-021-02156-5. Epub 2021 Sep 28. Naunyn Schmiedebergs Arch Pharmacol. 2021. PMID: 34581836 Free PMC article.
21 results